REBOXETINE VERSUS METHYLPHENIDATE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ARABGOL F.; JOBRANI P.; DAVARI ASHTIANI R.; PANAGHI L.; SHAMS J.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Researcher Bulletin of Medical Sciences Year:2007 | Volume:12 | Issue:2 (56) Page(s): 79-86

Download Full-Text

Persian Verion

View:

992

Download:

Cites:

Information Journal Paper

Title

REBOXETINE VERSUS METHYLPHENIDATE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Author(s)

Keywords

METHYLPHENIDATEQ2

REBOXETINEQ3

ATTENTION DEFICIT HYPERACTIVITY DISORDERQ3

Abstract

Background: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) is a prevalent disorder among children and stimulant remedies are the drugs of choice for its treatment. A substantial minority of stimulant-treated patient does not respond adequately or cannot tolerate the associate adverse effects and these difficulties highlight the need for alternative effective medications. This study was conducted to evaluate the efficacy and tolerability of REBOXETINE compared to that of METHYLPHENIDATE in treatment of children and adolescents with ADHD. Materials and Methods: Thirty three children (7-16 years of age) diagnosed with ADHD, participated in a 6-week double-blind clinical trial with REBOXETINE (4-6mg/d) and METHYLPHENIDATE (25-50mg/d). The principal measure of the outcome was the Teacher and Parent ADHD Rating Scale. Patients were assessed by a child psychiatrist at baseline of treatment and 2 , 4 and 6 weeks of medication, respectively. Results: No significant differences were observed between two protocols of the parent and teacher ADHD rating scale scores and in terms of the dropouts and both groups showed a significant improvement in ADHD symptoms over the 6 weeks of treatment. The most common adverse effects seen with REBOXETINE were sedation/drowsiness and mild to sever decrease in appetite. Conclusion: Our finding must be considered preliminary; however, they do suggest that REBOXETINE may be beneficial in the treatment of ADHD. Further research is needed to clarify the potential benefit for comorbid depression and anxiety with ADHD and profile of side effects.

Cites

No record.

References

No record.

Cite

APA: Copy

ARABGOL, F., JOBRANI, P., DAVARI ASHTIANI, R., PANAGHI, L., & SHAMS, J.. (2007). REBOXETINE VERSUS METHYLPHENIDATE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), 12(2 (56)), 79-86. SID. https://sid.ir/paper/18585/en

Vancouver: Copy

ARABGOL F., JOBRANI P., DAVARI ASHTIANI R., PANAGHI L., SHAMS J.. REBOXETINE VERSUS METHYLPHENIDATE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH)[Internet]. 2007;12(2 (56)):79-86. Available from: https://sid.ir/paper/18585/en

IEEE: Copy

F. ARABGOL, P. JOBRANI, R. DAVARI ASHTIANI, L. PANAGHI, and J. SHAMS, “REBOXETINE VERSUS METHYLPHENIDATE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER,” RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), vol. 12, no. 2 (56), pp. 79–86, 2007, [Online]. Available: https://sid.ir/paper/18585/en

Related Journal Papers